ATHIRA

Welcome to the Brand page for “ATHIRA”, which is offered here for Prescription pharmaceutical preparations, prescription pharmaceutical compounds in the nature of small molecule chemical compounds, and prescription pharmaceutical compositions for use in the prevention and treatment of neurodegenerative, neurologic, neuropsychiatric and inflammatory disorders such as alzheimer's disease, parkinson's disease, multiple sclerosis, neuropathy and neuropathic pain, stroke, depression, insomnia, schizophrenia, hearing loss and rheumatoid arthritis;pharmaceutical research and development; pharmaceutical drug development services;.

Its status is currently believed to be active. Its class is unavailable. “ATHIRA” is believed to be currently owned by “Athira Pharma, Inc.”